Ds Healthcare Group, Inc. (DSKX): Daniel Khesin , CEO and CFO of Ds Healthcare Group, Inc. sold 175,000 shares on Nov 8, 2015. The Insider selling transaction was reported by the company on Jul 19, 2016 to the Securities and Exchange Commission. The shares were sold at $242,000.00 per share for a total value of $42349998 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 25, 2015, Daniel Khesin (CEO) purchased 3,000 shares at $3.25 per share price.On Jun 19, 2015, Mark Edward Wolfson (director) sold 27,650 shares at $4.28 per share price.
DS Healthcare Group Inc. (DS Healthcare) doing business as DS Laboratories is a personal-care product development and marketing company. The Company offers the following lines of products: hair care skin care personal care and OTC Drugs. The Company is a provider of Liposome Technology which acts as a carrier agent and Nanosome Technology which acts as a delivery vehicle and infuses active compounds into focused cells of its products. The Company formulates markets and sells products through specialty retailers spas salons pharmacies and other distributors. The Company’s principal thinning hair products include Revita Revita LT and Spectral; Hair Care products consist of Dandrene Nia and Radia; Skin Care products comprises Hydroviton.CR Keramene Oligio.DX and Trioxil and Personal Care products include Nirena and Spectral.Lash all of which are marketed under the DS Laboratories brand.